Fleming Fund Implementation in Kenya: What Have We Learned About Strengthening One Health Antimicrobial Resistance Surveillance for Decision-making?
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciag500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Evelyn Wesangula und 32 weiteren Autor:innen. Beteiligte Einrichtung: Family Health and Infectious Diseases, East Central and Southern Africa Health Community, Arusha, Tanzania. Hauptthemen laut MEDLINE: One Health, Decision Making, Drug Resistance, Bacterial, Epidemiological Monitoring. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Department of Health and Social Care, Fleming Fund.
Abstract (Originalsprache)
Background
Kenya has moved from fragmented, pilot-based antimicrobial resistance (AMR) surveillance toward a coordinated One Health system, and its experience, pathways of change, and remaining gaps are relevant for other low- and middle-income settings working to operationalize One Health AMR surveillance.
Methods
Here, we report a narrative overview of programmatic learning using 2018 as the pre-Fleming Fund baseline, drawing on national and global surveillance reports, monitoring frameworks from the Quadripartite indicators, qualitative evidence on governance, implementation and policy evolution across the One Health sectors, and Fleming Fund documentation.
Results
Since 2018, AMR surveillance expanded from 2 human health sites to 30 human, animal, and environmental sites by 2025. National reports evolved to integrate AMR, antimicrobial consumption, and antimicrobial use data; routine reporting to global platforms matured; and outputs such as dashboards, reports, and policy briefs informing stewardship, Infection Prevention and Control, regulatory action, and policy decisions. External benchmarks showed improvement in AMR-related capacity, with World Health Organization Joint External Evaluation scores moving from limited to demonstrated capacity for surveillance and multisectoral coordination.
Conclusions
Kenya's experience suggests that sustainable progress depends on embedding AMR surveillance within government-led governance structures, technical systems, and coordinated partner support, but sustaining gains will require predictable financing and routine data use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Family Health and Infectious Diseases, East Central and Southern Africa Health Community, Arusha, Tanzania.
- Itad, United Kingdom.
- Global Health-AMR, Nairobi, Kenya.
- Division of Quality Improvement, Infection Prevention and Control and Antimicrobial Resistance, Kenya National Public Health Institute, Nairobi, Kenya.
- State Department of Livestock Development, Directorate of Veterinary Services, Nairobi, Kenya.
- National Laboratory Science and Biosecurity, Kenya National Public Health Institute, Nairobi, Kenya.
ORCID-Profile: Evelyn Wesangula, Nkatha Gitonga, Emmanuel Tanui, Josiah Mwenda, Irungu John Kamau, Loice Achieng Ombajo, Arshnee Moodley, John A Crump, Kate Macintyre, Rebecca Maudling, Raheelah Ahmad, Lamiaa Shehata, Tim Shorten
Förderung
- UK Department of Health and Social Care
- Fleming Fund
Zitieren
APA
Wesangula, E., Gitonga, N., Tanui, E., Ndanyi, R., Githii, S., Muasa, B. S., Omondi, E., Fèvre, E. M., Muloi, D. M., Kassim, A., Mwenda, J., Mbindyo, C. M., Kamau, I. J., Ombajo, L. A., Revathi, G., Chuchu, V., Mataka, A., Mouiche, M. M. M., Moodley, A., …, & Shorten, T. (2026). Fleming Fund Implementation in Kenya: What Have We Learned About Strengthening One Health Antimicrobial Resistance Surveillance for Decision-making?. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag500
Vancouver
Wesangula E, Gitonga N, Tanui E, Ndanyi R, Githii S, Muasa BS, et al. Fleming Fund Implementation in Kenya: What Have We Learned About Strengthening One Health Antimicrobial Resistance Surveillance for Decision-making?. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag500
BibTeX
@article{Wesangula2026,
author = {Wesangula, Evelyn and Gitonga, Nkatha and Tanui, Emmanuel and Ndanyi, Romona and Githii, Susan and Muasa, Bridgit Syombua and Omondi, Eunice and Fèvre, Eric M and Muloi, Dishon M and Kassim, Ali and Mwenda, Josiah and Mbindyo, Christine Minoo and Kamau, Irungu John and Ombajo, Loice Achieng and Revathi, Gunturu and Chuchu, Veronica and Mataka, Anafi and Mouiche, Moctar M M and Moodley, Arshnee and Fenwick, Stanley and Nanjebe, Deborah and Bibangamba, Lillian and Mubangizi, Patrick and Leslie, Toby and Crump, John A and Bhutta, Zulfiqar Ahmed and Walsh, Tim and Macintyre, Kate and Maudling, Rebecca and Mugabe, Solomon and Ahmad, Raheelah and Shehata, Lamiaa and Shorten, Tim},
title = {Fleming Fund Implementation in Kenya: What Have We Learned About Strengthening One Health Antimicrobial Resistance Surveillance for Decision-making?},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag500}
}
EUVIMED